New guidelines and standards have facilitated a robust pipeline of biosimilars in the United States.
By Dan Steiber, RPH, Specialty Pharmacy Times, Editor-in-Chief & Executive Vice President
Advertisement
Articles by By Dan Steiber, RPH, Specialty Pharmacy Times, Editor-in-Chief & Executive Vice President
Advertisement
Latest Updated Articles
- Finally Getting Real: Biosimilars
Published: July 24th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
2
Targeted α-Particle Radioligand Therapy Shows Promising Activity, Low Toxicity in SSTR2-Positive Neuroendocrine Tumors
3
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
4
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
5
